Vida Ventures
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Seed, Early Stage, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States
Industries Focus
- Healthcare
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Medical Research
- Regenerative Medicine
- Immunotherapy
- Oncology
- Neurology
- Cardiology
- Genomics
- Rare Diseases
- Biomanufacturing
Investment Size:
1,000,000 to 30,000,000 USD
Investor Details Founded: 2017
Vida Ventures is a life sciences venture capital firm dedicated to funding and developing innovative medical breakthroughs that aim to significantly improve patient outcomes. Founded in 2017 by a group of scientists, physicians, entrepreneurs, and investors, the firm has a bicoastal presence with offices in Boston, Massachusetts, and San Francisco, California. Vida Ventures manages approximately $1.7 billion in assets across its funds, including Vida Ventures III, which closed in July 2021 with $825 million. The firm's portfolio includes companies such as Allogene Therapeutics, Kronos Bio, and Homology Medicines, reflecting its commitment to advancing transformative biomedical innovations. Vida Ventures focuses on a flexible investment approach, supporting companies at various stages and across therapeutic areas, with a particular emphasis on therapeutics. The firm's mission is to bring science to life by advancing biomedical innovations that have the potential to make a meaningful difference in patients' lives.
Requirements
- Focus on transformative biomedical innovations
- Potential to significantly improve patient outcomes
- Companies at various stages and across therapeutic areas
- Emphasis on therapeutics
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- Allogene Therapeutics
- Kronos Bio
- Homology Medicines
- Asklepios BioPharmaceutical
- Peloton Therapeutics
- A2 Biotherapeutics
- Bait Therapeutics
- Kadiant
- Neogene Therapeutics
- Oyster Point Pharma
- Pionyr Immunotherapeutics
- Praxis Precision Medicines
- Precision Medicine Group
- Sutro Biopharma
Mentioned In
-
$49.95
-
$14.95
-
$24.95
-
$19.95
-
$24.95
Claim this Investor
Are you an official representative of Vida Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim